Cargando…
Poly (ADP-Ribose) and α–synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity
BACKGROUND/OBJECTIVE: Despite multiple attempts, no surrogate biomarker of Parkinson disease (PD) has been definitively identified. Alternatively, identifying a non-invasive biomarker is crucial to understanding the natural history, severity, and progression of PD and to guide future therapeutic tri...
Autores principales: | Lucien, Fabrice, Benarroch, Eduardo E., Mullan, Aidan, Ali, Farwa, Boeve, Bradley F., Mielke, Michelle M., Petersen, Ronald C., Kim, Yohan, Stang, Cole, Camerucci, Emanuele, Ross, Owen A., Wszolek, Zbigniew K., Knopman, David, Bower, James, Singer, Wolfgang, Savica, Rodolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993007/ https://www.ncbi.nlm.nih.gov/pubmed/35395000 http://dx.doi.org/10.1371/journal.pone.0264446 |
Ejemplares similares
-
40-Year Incidence of Early-Onset Parkinson’s Disease in Southeast Minnesota
por: Camerucci, Emanuele, et al.
Publicado: (2023) -
Sleep Disorders in Early-Onset Parkinsonism: A Population-Based Study
por: McCarter, Stuart J., et al.
Publicado: (2023) -
Risk of hospitalization in synucleinopathies and impact of psychosis
por: Piat, Capucine, et al.
Publicado: (2023) -
Deep Brain Stimulation and Treatment Outcomes of Young- and Late-Onset (≤55 Years) Parkinson's Disease: A Population-Based Study
por: Camerucci, Emanuele, et al.
Publicado: (2021) -
Poly (ADP-ribose) in the pathogenesis of Parkinson's disease
por: Lee, Yunjong, et al.
Publicado: (2014)